Cited by 792Cancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesImmune cells in cancer

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Open access

Zhang, Yuanyuan, Chen, Hongyan, Mo, Hongnan, Hu, Xueda, Gao, Ranran, Zhao, Yahui, Liu, Baolin, Niu, Lijuan, Sun, Xiaoying, Yu, Xiao, Wang, Yong, Chang, Qing, Gong, Tongyang, Guan, Xiuwen, Hu, Ting, Qian, Tianyi, Xu, Binghe, Ma, Fei, Zhang, Zemin, Liu, Zhihua·2021·Cancer Cell

DOI 10.1016/j.ccell.2021.09.010

Open this paper in CoChat — free account Open PDF

Abstract

In triple-negative breast cancer (TNBC), the benefit of combining chemotherapy with checkpoint inhibitors is still not very clear. We utilize single-cell RNA- and ATAC-sequencing to examine the immune cell dynamics in 22 patients with advanced TNBC treated with paclitaxel or its combination with the anti-PD-L1 atezolizumab. We demonstrate that high levels of baseline CXCL13 + T cells are linked to the proinflammatory features of macrophages and can predict effective responses to the combination therapy. In responsive patients, lymphoid tissue inducer (LTi) cells, follicular B (Bfoc) cells, CXCL13 + T cells, and conventional type 1 dendritic cells (cDC1) concertedly increase following the combination therapy, but instead decrease after paclitaxel monotherapy. Our data highlight the importance of CXCL13 + T cells in effective responses to anti-PD-L1 therapies and suggest that their reduction by paclitaxel regimen may compromise the clinical outcomes of accompanying atezolizumab for TNBC treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2021.09.010

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,724
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881

Flagged first, then by citations

Show all 77 references

Sorted by citations

Items 301–400 of 792

Study on the Chemical Constituents, Pharmacological Activities, and Clinical Application of Taxus
Gao, X., Guo, Y., Chen, K., Wang, H., & Xie, W. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x24500538 · Cited by 14
Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders
Li, X., Liu, Y., Gui, J., Gan, L., & Xue, J. (2024) · Advanced Science · doi:10.1002/advs.202400702 · Cited by 17
Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy
Maliah, A., Santana-Magal, N., Parikh, S., Gordon, S., Reshef, K., Sade, Y., Khateeb, A., Richter, A., Gutwillig, A., Parikh, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52079-x · Cited by 14
Single‐cell and spatial omics unravel the spatiotemporal biology of tumour border invasion and haematogenous metastasis
Cheng, X., Cao, Y., Liu, X., Li, Y., Li, Q., Gao, D., & Yu, Q. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70036 · Cited by 13
scATAnno: Automated Cell Type Annotation for Single-cell ATAC-seq Data
Jiang, Y., Hu, Z., Lu, F., Lynch, A. W., Jiang, J., Zhu, A., Zeng, Z., Zhang, Y., Wu, G., Xie, Y., et al. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf108 · Cited by 19
Self-citation
Uncovering gene and cellular signatures of immune checkpoint response via machine learning and single-cell RNA-seq
Pinhasi, A., & Yizhak, K. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00883-z · Cited by 15
Epigenetic orchestration of cancer-immune dynamics: mechanisms, technologies, and clinical advancements
Lu, Y., Ma, S., Chan, Y.-T., Wu, Y., Feng, Y., & Wang, N. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.08.057 · Cited by 15
Single-cell profiling of T cells uncovers a tissue-resident memory-like T-cell subset associated with bidirectional prognosis for B-cell acute lymphoblastic leukemia
Lai, W., Wang, X., Liu, L., Xu, L., Mao, L., Tan, J., Zha, X., Zhan, H., Lei, W., Lan, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.957436 · Cited by 13
CD4+ cytotoxic T cells: an emerging effector arm of anti-tumor immunity
Jeong, S., Jang, N., Kim, M., & Choi, I. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0014 · Cited by 15
Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel
Zhuang, Q., Zhao, B., Lin, Z., Liang, Y., Zhao, Q., Wang, Y., Liao, N., Tu, H., Zheng, Y., Chen, H., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04983-z · Cited by 14
Self-citation
Analysis of intercellular communication in the osteosarcoma microenvironment based on single cell sequencing data
Chen, F., Liu, J., Yang, T., Sun, J., He, X., Fu, X., Qiao, S., An, J., & Yang, J. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100493 · Cited by 14
Prognostic significance and mechanisms of CXCL genes in clear cell renal cell carcinoma
Shen, J., Wang, R., Chen, Y., Fang, Z., Tang, J., Yao, J., Gao, J., Chen, X., & shi, X. (2023) · Aging · doi:10.18632/aging.204922 · Cited by 13
Advances in the Management of Early-Stage Triple-Negative Breast Cancer
Bhardwaj, P. V., Wang, Y., Brunk, E., Spanheimer, P. M., & Abdou, Y. G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512478 · Cited by 14
Self-citation
Progress in personalized immunotherapy for patients with brain metastasis
Patel, L. R., Kolundžić, N., & Abedalthagafi, M. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00812-0 · Cited by 14
High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer
Xu, S., Li, D., Ning, T., Lu, Y., Sun, Y., Bai, H., Qiao, L., Deng, T., & Liu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1551259 · Cited by 12
B cells are major players in cancer immunity
Bouloudani, T., Pupier, G., Sautès‐Fridman, C., & Fridman, W. H. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107064 · Cited by 12
Insights into the Mechanisms of Immune‐Checkpoint Inhibitors Gained from Spatiotemporal Dynamics of the Tumor Microenvironment
Zhang, Y., & Liu, Z. (2025) · Advanced Science · doi:10.1002/advs.202508692 · Cited by 13
Self-citation
Celastrol liposomes enhance anti-PD-L1 in triple-negative breast cancer by reprogramming immunosuppressive microenvironment driven by cancer-associated adipocytes
Li, Y., Zhang, H., Wei, J., Jin, W., Tong, Q., Ye, Y., Xie, Q., Li, Q., Cheng, G., & Xiong, Y. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157275 · Cited by 12
An SPP1-SOCS1 pathway constrains interferon responses in tumor-associated macrophages and shapes an immunosuppressive tumor microenvironment
sun, L., Chu, X., Kong, T., Chen, X., Ru, J., Gao, Q., Zhou, W., Wang, X., Cheng, S., Zhu, L. L., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.04.001 · Cited by 17
Self-citation
Molecular subtyping and immune score system by a novel pyroptosis-based gene signature precisely predict immune infiltrating, survival and response to immune-checkpoint blockade in breast cancer
Zeng, X., Huang, X., Yin, L., Yu, H., Wang, S., & Li, L. (2023) · Cancer Genetics · doi:10.1016/j.cancergen.2023.07.007 · Cited by 12
Beneficial mechanisms of dimethyl fumarate in autoimmune uveitis: insights from single-cell RNA sequencing
Zhu, L., Li, H., Peng, X., Li, Z., Zhao, S., Wu, D., Chen, J., Li, S., Jia, R., Li, Z., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03096-6 · Cited by 12
The Impact of Neoadjuvant Chemotherapy on Ovarian Cancer Tumor Microenvironment: A Systematic Review of the Literature
Spagnol, G., Ghisoni, E., Morotti, M., Tommasi, O. D., Marchetti, M., Bigardi, S., Tuninetti, V., Tasca, G., Noventa, M., Saccardi, C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137070 · Cited by 12
The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients
Ji, Z., Li, J., Zhang, S., Jia, Y., Zhang, J., & Guo, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1480520 · Cited by 13
Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration
Sakai, S. A., Saeki, K., Chi, S., Hamaya, Y., Du, J., Nakamura, M., Hojo, H., Kojima, T., Nakamura, Y., Bando, H., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0610 · Cited by 12
Matairesinol repolarizes M2 macrophages to M1 phenotype to induce apoptosis in triple-negative breast cancer cells
Chaudhary, A., Patil, P. H., Raina, P., & Kaul-Ghanekar, R. (2024) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2024.2425028 · Cited by 13
Dendritic cells in triple-negative breast cancer: From pathophysiology to therapeutic applications
Sebastião, A. I., Simões, G., Oliveira, F., Mateus, D., Falcão, A. C., Carrascal, M. A., Gomes, C. M. F., Neves, B. M., & Cruz, M. T. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102884 · Cited by 14
CXCL13 Expression Promotes CAR T Cell Antitumor Activity and Potentiates Response to PD‐1 Blockade
Zhou, Y., Zhao, W., Zhu, Y., Liu, H., Sun, Y., Gong, Z., Li, X., Liu, Z., Wen, K., Wang, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202508095 · Cited by 12
Self-citation
Immunological and pathological characteristics of brain parenchymal and leptomeningeal metastases from non-small cell lung cancer
Zhou, C., Shan, S., Wen, L., Liu, D., Shan, C., Jin, X., Zhou, Z., Li, H., Li, J., Wang, L., et al. (2025) · Cell Discovery · doi:10.1038/s41421-025-00828-7 · Cited by 19
A spatially resolved atlas of gastric cancer characterises a lymphocyte-aggregated region
Gao, S., Qin, S., Wang, D., Wang, A., Zhu, L., Li, Y., Shi, Q., Fan, H., Bo, Y., Zhong, Y., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68612-z · Cited by 12
Self-citation
Engineering NK and T cells with metabolite-sensing receptors to target solid tumors
Kim, Y., Tsai, M. K., Sun, C., Laveroni, O., Akana, R. V., Frombach, K. R., & Jerby‐Arnon, L. (2026) · Nature Immunology · doi:10.1038/s41590-026-02473-y · Cited by 14
Single-cell technologies in psoriasis
Cui, N., Xu, X., & Zhou, F. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110242 · Cited by 11
Tumor necrosis factor receptor 2 promotes endothelial cell-mediated suppression of CD8+ T cells through tuning glycolysis in chemoresistance of breast cancer
Hu, Y., Lou, X., Zhang, K., Pan, L., Bai, Y., Wang, L., Wang, M., Yan, Y., Wan, J., Yao, X., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05472-5 · Cited by 11
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Msaouel, P., Yu, K. F., Yuan, Y., Chen, J., Yan, X., Karki, M., Duan, F., Sheth, R. A., Rao, P., Sircar, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55642-8 · Cited by 11
Nanoparticles Modulating the Immune Microenvironment in Breast Cancer Treatment
Guo, L., Wu, J., Lu, W., Li, J., Wang, Y., Yang, H. L., & Wang, T.-Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s492713 · Cited by 11
Self-citation
Integrated single-cell and bulk transcriptomic analysis identifies a novel macrophage subtype associated with poor prognosis in breast cancer
Wang, Q., Yu, Y., Ruan, L., Huang, M., Chen, W., Sun, X., Liu, J., & Jiang, Z. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03750-w · Cited by 12
Self-citation
Deciphering the Immunomodulatory Function of GSN + Inflammatory Cancer‐Associated Fibroblasts in Renal Cell Carcinoma Immunotherapy: Insights From Pan‐Cancer Single‐Cell Landscape and Spatial Transcriptomics Analysis
Li, S., Zhou, X., Feng, H., Huang, K., Chen, M., Lin, M., Lin, H., Deng, Z., Chen, Y., Liao, W., et al. (2025) · Cell Proliferation · doi:10.1111/cpr.70062 · Cited by 12
Self-citation
Multi-omics analyses of the heterogenous immune microenvironment in triple-negative breast cancer implicate UQCRFS1 potentiates tumor progression
Tang, Y., Xu, A., Xu, Z., Xie, J., Huang, W., Zhang, L., Chen, Y., Yang, L., Du, S., & Wang, K. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00672-1 · Cited by 14
Immune activation and evolution through chemotherapy plus checkpoint blockade in triple-negative breast cancer.
Koh, S., & Ellisen, L. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.11.001 · Cited by 11
A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer
Angius, A., Scanu, A. M., Arru, C., Muroni, M. R., Carru, C., Porcu, A., Cossu‐Rocca, P., & Miglio, M. R. D. (2021) · Medicina · doi:10.3390/medicina57111257 · Cited by 10
Cancer Immunology: Immune Escape of Tumors—Expression and Regulation of HLA Class I Molecules and Its Role in Immunotherapies
Wang, Y., Jasinski‐Bergner, S., Wickenhauser, C., & Seliger, B. (2022) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000389 · Cited by 11
Self-citation
Metabolic Heterogeneity and Potential Immunotherapeutic Responses Revealed by Single-Cell Transcriptomics of Breast Cancer
Tang, S., Wang, Q., Sun, K., Song, Y., Liu, R., Tan, X., Li, H., Lv, Y., Yang, F., Zhao, J., et al. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01952-7 · Cited by 11
Exploration of shared TF-miRNA‒mRNA and mRNA-RBP-pseudogene networks in type 2 diabetes mellitus and breast cancer
Tong, W., Wenze, G., Libing, H., Cao, Y., Zhao, H., Xi, G., Yang, X., Yi, G., & Fu, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915017 · Cited by 12
αTIGIT-IL2 achieves tumor regression by promoting tumor-infiltrating regulatory T cell fragility in mouse models
Wang, T.-C., Xu, Y., Zhang, Z., Wu, Y., Chen, L., Zheng, X., Peng, H., Zou, Q., Sun, R., Ma, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64296-z · Cited by 10
Self-citation
Emerging involvement of CXCL13 in cancer development and progression
Argyris, D. G., Johnson, L., Hägglöf, T., Filippou, P. S., & Karagiannis, G. S. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.12.005 · Cited by 10
Tumor Microenvironment Onmyoji: Cytokines with Dual Protumor and Antitumor Roles
Wang, Y., Lin, A., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2026) · 癌症：英文版 · doi:10.34133/cancomm.0008 · Cited by 10
Self-citation
Decoding the CAF–TAM axis: multi-omics dissection and therapeutic targeting of stromal–immune crosstalk in the tumor microenvironment
Fu, Y., Li, M., Wu, S., Wang, J., & Wang, S. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08685-2 · Cited by 11
Multifunctional Responsive Nanoplatform as Immunotherapeutic Regulator to Target Triple‐Negative Breast Cancers via Mechanotransduction
Li, W., Ge, L., Zhong, D., Zhang, Y. X., Xiao, S., Zhang, D. H., Liu, Z., Wen, Z., Wang, J., Chen, Q., et al. (2026) · Advanced Functional Materials · doi:10.1002/adfm.75937 · Cited by 10
Self-citation
Radiomic models based on magnetic resonance imaging predict the spatial distribution of CD8+ tumor-infiltrating lymphocytes in breast cancer
Jeon, S. H., Kim, S., Na, K., Seo, M., Sohn, Y., & Lim, Y. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1080048 · Cited by 10
Infiltrating myeloid cell diversity determines oncological characteristics and clinical outcomes in breast cancer
Yang, C., Liu, J., Zhao, S., Shang, Q., Ren, F., Feng, K., Zhang, R., Kang, X., Wang, X., & Wang, X. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01669-6 · Cited by 10
Metabolic predictors of response to immune checkpoint blockade therapy
Shorer, O., & Yizhak, K. (2023) · iScience · doi:10.1016/j.isci.2023.108188 · Cited by 9
scCURE identifies cell types responding to immunotherapy and enables outcome prediction
Zou, X., Liu, Y., Wang, M., Zou, J., Shi, Y. Y., Su, X., Xu, J., Tong, H. H. Y., Ji, Y., Gui, L., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100643 · Cited by 12
ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy
Li, J., Meng, Z., Cao, Z., Lü, W., Yang, Y., Li, Z., & Lü, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1304183 · Cited by 11
Inflammatory dendritic cells restrain CD11b+CD4+ CTLs via CD200R in human NSCLC
Lin, M., Chen, D., Shao, Z., Liu, Q., Hao, Z., Xin, Z., Chen, Y., Wu, W., Chen, X., He, T., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113767 · Cited by 10
IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer.
Li, L., Fei, Y.-J., Dong, T., Song, Y.-X., Chen, X., Zhang, H.-D., Zhou, H., Liang, M., & Tang, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112093 · Cited by 11
Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy
Wu, S., Jiang, H., Zhang, F., Wu, Y., Jiao, J., Fang, W., Wu, Y., Lang, Y., Chen, N., Zhong, Z., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03718-1 · Cited by 10
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
Leon-Ferre, R. A., Whitaker, K. R., Suman, V. J., Hoskin, T. L., Giridhar, K. V., Moore, R. M., Al-Jarrad, A., McLaughlin, S. A., Northfelt, D., Hunt, K. N., et al. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01848-z · Cited by 11
Leveraging preclinical models of metastatic breast cancer
Pedroza, D. A., Gao, Y., Zhang, X. H.-F., & Rosen, J. M. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189163 · Cited by 11
Apoptotic breast cancer cells after chemotherapy induce pro-tumour extracellular vesicles via LAP-competent macrophages
Zhang, Q., Liu, X., Wei, Q., Xiong, S., Luo, W., zhou, Y., Cao, J., Xu, X., Liu, R., Tang, X., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103485 · Cited by 10
An automatic annotation tool and reference database for T cell subtypes and states at single-cell resolution
Shen, W., Zhang, C., Gu, Y.-M., Luo, T., Chen, S., Yue, T., Xie, G., Liao, Y. C., Yuan, Y., Lei, Q., et al. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2025.02.043 · Cited by 12
CD4+ anti-TGF-β CAR T cells and CD8+ conventional CAR T cells exhibit synergistic antitumor effects
Zheng, D., Qin, L., Lv, J., Che, M., He, B., Zheng, Y., Lin, S., Qi, Y., Li, M., Tang, Z., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102020 · Cited by 11
Self-citation
The dynamic immune behavior of primary and metastatic ovarian carcinoma
Stur, E., Peng, F., Teng, P.-N., Bayraktar, E., Hu, M., Corvigno, S., Brown, D. J., Lee, S., Moore, K. N., Bateman, N. W., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00818-8 · Cited by 12
Resistance to anti-LAG-3 plus anti-PD-1 therapy in head and neck cancer is mediated by Sox9+ tumor cells interaction with Fpr1+ neutrophils
Wang, X., Cheng, M., Chen, S., Zhang, C., Ling, R., Qiu, S., Chen, K., Zhou, B., Li, Q., Lei, W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59050-4 · Cited by 11
Upstream open reading frame translation enhances immunogenic peptide presentation in mitotically arrested cancer cells
Kowar, A., Becker, J. P., Pizzo, R. D., Tang, Z., Champagne, J., Wellach, K., Samimi, K., Galindo‐Albarrán, A., Körner, P.-R., Navarro, J. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63405-2 · Cited by 12
The interplay between eosinophils and T cells in breast cancer immunotherapy
Zerdes, I., Matikas, A., & Foukakis, T. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13413 · Cited by 9
Single-cell transcriptome analysis revealed the immune profile of PD-1 blockade in gallbladder carcinoma liver metastasis
Xie, L., Ning, Z., Hua, Y., Wang, P., & Meng, Z. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000131 · Cited by 10
Decoding Human Biology and Disease Using Single-Cell Omics Technologies
Shi, Q., Chen, X., & Zhang, Z. (2023) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2023.06.003 · Cited by 11
Self-citation
Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer
Yan, H., Huang, J., Li, Y., & Zhao, B. (2024) · Biology of Sex Differences · doi:10.1186/s13293-024-00598-z · Cited by 11
Dissection of triple-negative breast cancer microenvironment and identification of potential therapeutic drugs using single-cell RNA sequencing analysis
Cheng, W., Mi, W., Wang, S., Wang, X., Jiang, H., Chen, J. W., Yang, K., Jiang, W., Ye, J., Guo, B., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.100975 · Cited by 10
Self-citation
MIR4435-2HG: A novel biomarker for triple-negative breast cancer diagnosis and prognosis, activating cancer-associated fibroblasts and driving tumor invasion through EMT associated with JNK/c-Jun and p38 MAPK signaling pathway activation
Gu, P., Ding, W., Zhu, W., Shen, L., Zhang, L., Wang, W., Wang, R., Wang, W., Wang, Y., Yan, B., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113191 · Cited by 10
Self-citation
A single dose of pembrolizumab treatment causing a profound and durable response in lung cancer
Kondo, Y., Kunishige, M., Kadota, N., Okano, Y., Machida, H., Hatakeyama, N., Naruse, K., Shinohara, T., & Takeuchi, E. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14314 · Cited by 10
Breaking the Immune Complexity of the Tumor Microenvironment Using Single-Cell Technologies
Caligola, S., Sanctis, F. D., Canè, S., & Ugel, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.867880 · Cited by 10
Spatial and Compositional Biomarkers in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast CancerPreprint
Mi, H., Varadhan, R., Cimino‐Mathews, A., Emens, L. A., Santa-Maria, C. A., & Popel, A. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.18.572234 · Cited by 10
Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes
Li, Z., Xie, Q., Zhao, F., Huo, X., Ren, D., Liu, Z., Zhou, X., Shen, G., & Zhao, J. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05791-6 · Cited by 9
Self-citation
An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade
Nitto, C. D., Ravazza, D., Gilardoni, E., Look, T., Sun, M., Prodi, E., Moisoiu, V., Pellegrino, C. E., Manz, M. G., Puca, E., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008504 · Cited by 9
Progress in understanding the regulatory mechanisms of immune checkpoint proteins PD-1 and PD-L1 expression
Wu, X., Zhu, Z., Zhang, J., Tian, M., & Zhao, P. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03835-4 · Cited by 11
Single-cell and spatial transcriptome profiling identifies cellular heterogeneity and immunosuppressive tumor microenvironment in inflammatory breast cancer
Sun, X., Xia, J., Jiang, H., Duan, T., Zhang, C., Li, Q., Yang, Z., Zhang, R., Ding, X., Gu, X., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.061 · Cited by 9
Self-citation
4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy
Cha, J., Kim, C. G., Sim, N. S., Kim, G., Son, W., Kim, D., Jung, Y., Hong, H. J., Lee, H. B., Kim, J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102408 · Cited by 14
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors
Ye, D., Desai, J., Shi, J., Liu, S. M., Shen, W., Liu, T., Shi, Y., Wang, D., Liang, L., Yang, S., et al. (2023) · Biomarker Research · doi:10.1186/s40364-023-00465-w · Cited by 9
Self-citation
Infiltration of Common Myeloid Progenitor (CMP) Cells is Associated With Less Aggressive Tumor Biology, Lower Risk of Brain Metastasis, Better Response to Immunotherapy, and Higher Patient Survival in Breast Cancer
Oshi, M., Wu, R., Khoury, T., Gandhi, S., Li, Y., Yamada, A., Ishikawa, T., Endo, I., & Takabe, K. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006428 · Cited by 8
Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy
Li, T., Guo, S., Xu, C., Zhang, M., Lyu, C., Xu, H., Hou, Z., Zhang, M., Li, X., Ren, J., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010534 · Cited by 9
Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody
Zhang, Z., Liang, X., Qin, J., & Lei, J. (2024) · Theory in Biosciences · doi:10.1007/s12064-024-00428-1 · Cited by 8
Self-citation
Single-cell Atlas reveals core function of CPVL/MSR1 expressing macrophages in the prognosis of triple-negative breast cancer
Wang, X., Li, L., Zhang, X., Zhang, M., Sun, Z., Yang, Y., Zhang, X., Yuan, Y., Zhang, Y., Chen, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1501009 · Cited by 8
Self-citation
Metformin Enhances PD ‐ L1 Inhibitor Efficacy in Ovarian Cancer by Modulating the Immune Microenvironment and RBMS3 Expression
Zhang, Q., Han, S., Zhang, X., Wang, Y., Li, T. X., & Yang, B. (2025) · The FASEB Journal · doi:10.1096/fj.202500906r · Cited by 8
Self-citation
Single-cell transcriptomics of the myeloid milieu reveals an angiogenic niche in triple-negative breast cancer
Choi, Y., Shim, M., Kim, S. H., Kim, D. K., Jeong, J., Byeon, J., Jang, G., Kim, J., Robson, P., Lee, C., et al. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01571-5 · Cited by 10
DC subsets and states unraveled across human juxtatumoral and malignant tissues
Mulder, K., Gardet, M., Kong, W. T., Patel, A. A., Calvez, A., Gessain, G., de la Calle‐Fabregat, C., Piot, C., Blampey, Q., Poupaud, E., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02337-x · Cited by 12
16-h fasting optimizes cancer immunotherapy in mice and humans
Chen, S., Hu, T., Zhu, K., Liu, Y., Yang, Y., Li, X., He, J., Cui, W., Chi, Z., Yu, W., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.01.015 · Cited by 8
Self-citation
Ecotypes of triple-negative breast cancer in response to chemotherapy
Yan, Y., Lin, Y., Kumar, T., Bai, S., Thennavan, A., Li, J., Sei, E., Tran, T. M., Hu, M., Rao, M., et al. (2026) · Nature · doi:10.1038/s41586-026-10469-9 · Cited by 14
Immunotherapy resistance in triple-negative breast cancer: Mechanisms and emerging therapeutic strategies
Zhao, H., Tian, H., Nuerbieke, T., Ma, K., Li, W., Niu, X., Li, J., Ashby, C. R., Chen, Z., Zhou, T., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218690 · Cited by 9
Dendritic cell maturation in the tumor microenvironment
Miao, Y., Liu, Y., Tang, H., & Zhang, Z. (2023) · National Science Open · doi:10.1360/nso/20220053 · Cited by 9
Self-citation
Chromatin accessibility analysis reveals regulatory dynamics and therapeutic relevance of Vogt-Koyanagi-Harada disease
Shi, W., Ye, J., Shi, Z., Pan, C., Zhang, Q., Lin, Y., Luo, Y., Su, W., Zheng, Y., & Liu, Y. (2022) · Communications Biology · doi:10.1038/s42003-022-03430-9 · Cited by 8
Current situation of programmed cell death protein 1/programmed cell death ligand 1 inhibitors in advanced triple-negative breast cancer
Liang, Y., Liu, X., Li, K., & Li, H. (2022) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2022.02.07 · Cited by 8
Plac1 Remodels the Tumor Immune Evasion Microenvironment and Predicts Therapeutic Response in Head and Neck Squamous Cell Carcinoma
Meng, X., Liu, Z., Zhang, L., & He, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.919436 · Cited by 8
Self-citation
Chemoimmunotherapy in advanced esophageal squamous cell carcinoma: optimizing chemotherapy regimens for immunotherapy combinations
Liu, Z., Liu, J., & Li, Z. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01077-w · Cited by 8
Self-citation
Characterization of PDL1 enhanced siRNA/albumin liposome for effective therapeutic function in lung cancer
Zhang, L., Xie, G., Xiao, X., & Cheng, C. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04298-2 · Cited by 8
Immune-Related Gene Signatures to Predict the Effectiveness of Chemoimmunotherapy in Triple-Negative Breast Cancer Using Exploratory Subgroup Discovery
Kholod, O., Baskett, W. I., Mitchem, J. B., Kaifi, J. T., Hammer, R., Papageorgiou, C. N., & Shyu, C. (2022) · Cancers · doi:10.3390/cancers14235806 · Cited by 9
Single-cell RNA-seq reveals the metabolic status of immune cells response to immunotherapy in triple-negative breast cancer
Liu, P.-W., Lin, J., Hou, R., Cai, Z., Gong, Y., He, P., & Yang, J. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.107926 · Cited by 7
Single‐cell transcriptomics reveals antigen‐presenting capacity and therapeutic resistance potential of immunomodulatory endothelial cells in colorectal cancer
Wen, J. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1311 · Cited by 7
Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer
Fan, X., Qi, A., Zhang, M., Jia, Y., Li, S., Han, D., & Liu, Y. (2024) · Diagnostic Pathology · doi:10.1186/s13000-024-01513-1 · Cited by 7
Peripheral Blood–Derived PD-1/CD28–CD19 CAR–Modified PD-1+ T-Cell Therapy in Patients with Solid Tumors
Zhang, Z., Zhao, X., Zhao, Q., Chen, X., Li, C., Liu, Y., Shen, C., Song, L., Miao, L., Guo, F., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0037 · Cited by 7
Self-citation
scStateDynamics: deciphering the drug-responsive tumor cell state dynamics by modeling single-cell level expression changes
Guo, W., Li, X., Wang, D., Yan, N., Hu, Q., Yang, F., Zhang, X., Yao, J., & Gu, J. (2024) · Genome biology · doi:10.1186/s13059-024-03436-y · Cited by 8

Authors: Zhang, Y., Chen, H., Mo, H., Hu, X., Gao, R., Zhao, Y., Liu, B., Niu, L., Sun, X., Yu, X., Wang, Y., Chang, Q., Gong, T., Guan, X., Hu, T., Qian, T., Xu, B., Ma, F., Zhang, Z., & Liu, Z.
Affiliations: Peking University (CN)
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Cancer Hospital of Huanxing Chaoyang District Beijing (CN)
Corresponding author: Xu, Binghe
Ma, Fei
Zhang, Zemin
Liu, Zhihua
ORCID: Zhang, Yuanyuan
Chen, Hongyan
Mo, Hongnan
Hu, Xueda
Gao, Ranran
Zhao, Yahui
Liu, Baolin
Niu, Lijuan
Sun, Xiaoying
Yu, Xiao
Wang, Yong
Chang, Qing
Gong, Tongyang
Qian, Tianyi
Xu, Binghe
Ma, Fei
Zhang, Zemin
Liu, Zhihua
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2021-12
Volume: 39
Issue: 12
Pages: 1578-1593.e8
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccell.2021.09.010
OpenAlex: W3205385275
Cited by: 783
References: 77
Citations by year: 2026: 135 · 2025: 206 · 2024: 183 · 2023: 158 · 2022: 93 · 2021: 8
FWCI: 41.16
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Cancer Cell (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: National Natural Science Foundation of China (31991171, 81988101, 82030089, 91942307)
Chinese Academy of Meteorological Sciences (2016-I2M-1-001, 2017-I2M-3-004, 2019-I2M-1-003)
Peking University
Beijing Municipal Science and Technology Commission (Z201100005320014)
National Key Research and Development Program of China (2018YFC1312101, 2020YFA0803300)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: triple-negative breast cancer, PD-L1 blockade, atezolizumab, paclitaxel, immune cell dynamics, lymphoid tissue inducer cells, follicular B cells, conventional type 1 dendritic cells, single-cell RNA sequencing, single-cell ATAC-seq
MeSH terms: Immune Checkpoint Inhibitors, Female, Humans, Single-Cell Analysis, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks